Cyclobenzaprine has not been proven safe in human pregnancy, but animal studies at high doses have not shown birth defects. The FDA classified it as Pregnancy Category B, meaning animal reproduction studies found no fetal harm, but no well-controlled studies exist in pregnant women. That puts it in a gray zone: not clearly dangerous, but not confirmed safe either.
What Animal Studies Show
Reproduction studies in mice, rabbits, and rats tested cyclobenzaprine at doses up to 20 times the typical human dose. At lower doses (5 and 10 mg/kg/day), researchers saw no evidence of birth defects, embryo death, or fertility problems in any species. The offspring grew and survived normally.
At the highest dose tested in rats (20 mg/kg/day), there were some red flags: smaller litter sizes, smaller pups, lower pup survival rates, and reduced weight gain in the mothers. These effects appeared only at that top dose, which is far above what a person would typically take. Still, animal results don’t always translate directly to humans, and the lack of controlled human data is the main limitation.
Limited Human Evidence
Human data on cyclobenzaprine in pregnancy is extremely thin. Only one published case report documents birth defects following exposure around the time of conception, involving abnormalities of the mouth, spine, and ears. A single case report can’t establish a causal link, but it’s essentially all the direct human evidence available for early pregnancy exposure.
No large cohort studies have tracked pregnancy outcomes in women taking cyclobenzaprine, which means the actual risk of congenital malformations in humans remains unknown. This is a significant gap. For comparison, many common medications have been studied in thousands of pregnancies, giving a much clearer picture of their safety profile.
A Specific Risk in Late Pregnancy
One case report raises a more targeted concern about using cyclobenzaprine later in pregnancy. A full-term infant whose mother took cyclobenzaprine for chronic back pain developed respiratory distress shortly after birth. Testing revealed high blood pressure in the lungs and premature closure of a blood vessel called the ductus arteriosus, which normally stays open during fetal life and closes after birth.
The proposed explanation involves how cyclobenzaprine works in the body. The drug blocks the reuptake of certain brain chemicals (norepinephrine and serotonin), which in turn can suppress prostaglandin and nitric oxide production. These substances are what keep the ductus arteriosus open in the womb. Without them, the vessel can close too early, forcing the baby’s heart to pump against dangerously high lung pressure. The infant in this case responded well to treatment and survived, but the report flagged cyclobenzaprine use in late pregnancy as a potential cause of this complication.
Breastfeeding After Delivery
If you’ve been taking cyclobenzaprine and are wondering about nursing, the news is more reassuring. Two mothers on chronic cyclobenzaprine therapy (one taking 5 mg daily, the other 10 mg twice daily) had their breast milk tested over 12-hour periods. The drug did pass into milk, but at very low levels. The infants received only about 0.5% of the mother’s weight-adjusted dose, and neither infant showed any signs of sedation or other problems.
One adverse event involving breastfeeding was reported to U.S. poison control centers between 2001 and 2017: a 16-day-old infant exposed to cyclobenzaprine, acetaminophen, and oxycodone through breast milk developed slowed heart rate, low blood pressure, and breathing problems. Because three drugs were involved, it’s impossible to pin the reaction on cyclobenzaprine alone. Overall, the drug in breast milk appears to be well tolerated, though newborns and premature infants deserve closer monitoring for drowsiness and feeding difficulties.
Managing Muscle Pain During Pregnancy
Given the limited safety data, you may want to try non-drug approaches first. Muscle stretching is considered a first-line option for cramps and spasms. Massage, heat therapy, and relaxation techniques are also commonly used during pregnancy, though a Cochrane review noted that none of these have been rigorously studied in clinical trials for pregnant women either.
Magnesium, calcium, and certain vitamins (B, D, E) have all been tested for pregnancy-related muscle cramps in small studies, but the evidence is too weak to confidently recommend any of them. That same Cochrane review concluded it’s not yet possible to identify safe and effective interventions for muscle cramps in pregnancy with confidence, which underscores how limited the research is across the board.
If non-drug options aren’t providing relief and you’re considering cyclobenzaprine or another muscle relaxant, the decision comes down to weighing your pain and functional needs against the uncertain risks. The FDA label states the drug should be used during pregnancy “only if clearly needed,” which in practice means short-term use at the lowest effective dose when alternatives haven’t worked.